Developmental Changes in Neurotransmitter Receptor Binding in the Human Periaqueductal Gray

• Published in: Journal of neuropathology and experimental neurology 1996-04, Vol.55 (4), p.409-418
• Main Authors: Reddy, Sathya C, Panigrahy, Ashok, White, W Frost, Kinney, Hannah C
• Format: Article
• Language: English
• Subjects: Age Factors; Binding, Competitive; Biological and medical sciences; Brain - growth & development; Central nervous system; Central neurotransmission. Neuromudulation. Pathways and receptors; Fundamental and applied biological sciences. Psychology; Humans; Lysergic Acid Diethylamide - pharmacology; Naloxone - pharmacology; Neurotransmitter Agents - metabolism; Nicotine - pharmacology; Periaqueductal Gray - metabolism; Receptors, Kainic Acid - drug effects; Vertebrates: nervous system and sense organs
• ISSN: 0022-3069; 1554-6578
• DOI: 10.1097/00005072-199604000-00003

The periaqueductal gray (PAG) plays a central role in the integration of defense responses to threatening or stressful stimuli. Little is known about the neurochemical development of the human PAG around the time of birth, when the fetus makes the transition to extrauterine life and independent defense responses are needed. We analyzed receptor binding to selected neurotransmitters implicated in PAG function in 7 fetuses (19 to 26 gestational weeks), 9 infants (38 to 74 postconceptional weeks), 1 child (4 years), and 3 adults (20 to 68 years). Tissue autoradiography was used with radioligands for opioid, nicotinic, muscarinic, kainate, and serotoninergic receptors. By midgestation, binding to nicotinic, muscarinic, serotoninergic, opioid, and kainate receptors is already localized to the human PAG. The subsequent developmental profiles are unique for each radioligand. Binding to nicotinic and serotoninergic receptors decreases significantly from the fetal to mature periods, but at different tempos. In contrast, there is no significant change from midgestation to infancy for muscarinic, kainate, and opioid bindingbetween infancy and the mature period there is a downward trend in binding for muscarinic and kainate receptors and an upward trend for opioid receptors. This study provides baseline information about the neurochemical development of the human PAG in early life. This information is of value in considering the neurochemical substrate of the maturation of defense responses in human infancy, and in evaluating potential neurochemical disorders of the developing human PAG